Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03319719 · ClinicalTrials.gov registry record · NA
Evaluation of Pain With Belotero® Balance With Integral Lidocaine for Correction of the Nasolabial Folds
A NA study, sponsored by Merz North America.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT03319719 is a NA study that has completed, run by Merz North America. The registered enrollment target is 52 participants.
The verdict
NCT03319719, a NA study, has completed, sponsored by Merz North America.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
Demonstrate the effectiveness of Belotero Balance with lidocaine (Test group) for the reduction of injection-related pain in comparison to Belotero Balance without lidocaine (Control group) for the correction of NLFs. Identify and describe adverse events (AEs) and serious adverse events (SAEs) during the course of the study. Additionally, common treatment site responses (CTRs) will be assessed.
Interventions
- DEVICE Belotero® Balance with integral lidocaine
- DEVICE Belotero® Balance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2017-09-18 |
| Est. Completion | 2017-12-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03319719
The ClinicalTrials.gov registry entry for NCT03319719 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merz North America, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Belotero® Balance with integral lidocaine is the first listed.
NCT03319719 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03319719 about?
NCT03319719 is a clinical study titled "Evaluation of Pain With Belotero® Balance With Integral Lidocaine for Correction of the Nasolabial Folds". Demonstrate the effectiveness of Belotero Balance with lidocaine (Test group) for the reduction of injection-related pain in comparison to Belotero Balance without lidocaine (Control group) for the correction of NLFs. Identify and describe adverse events (AEs) and serious adverse events (SAEs) duri...
What is the current status of trial NCT03319719?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2017-09-18. Estimated completion is 2017-12-06.
What interventions are being tested in trial NCT03319719?
The interventions under investigation include: Belotero® Balance with integral lidocaine (DEVICE), Belotero® Balance (DEVICE).
Who is sponsoring clinical trial NCT03319719?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.